Welcome to the February 2013 issue of Pharmaceutical Technology Sourcing and Management, Pharmaceutical Technology’s and Pharmaceutical Technology Europe’s information resource on pharmaceutical ingredients, manufacturing, and the supply chain. In this issue, analysis of the strengths and weaknesses of the fine-chemicals and contract API market and insight on how to optimize facilities management. Plus the latest in nano-based drug delivery. And an update of pharmaceutical companies’ R&D efforts for neglected tropical diseases and other news from the pharmaceutical/biopharmaceutical companies and their suppliers relating to global health initiatives and sustainability.

Global Feature
Optimizing Facilities Management in the Pharma Industry
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
In the era of manufacturing capacity rationalizaton, tighter return on assets, and re-alignment of manufacturing assets to meet changing product demand, strategies for cost-effectively managing manufacturing and other facilities become ever-more crucial. A Q&A with UMS Advisory Services.

APIs
Cautious Times for Fine-Chemical Producers and Contract API Manufacturers
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
As contract API manufacturers, fine-chemical producers, and pharmaceutical companies prepare to attend Informex in Anaheim this month, the state of the industry shows improving conditions in certain sectors.

Advertisement:

Accelerate Sterile and Non-Sterile Clinical Trial Manufacturing with Single-Use Technologies
Live Webcast: Wednesday, March 6, 2013 at 11:00 AM ET
Register Free at http://www.pharmtech.com/accelerate

Drug Delivery
Advances in Nanotechnology-Based Drug Delivery
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Heated magnetic nanoparticles consisting of a liposome nanocontainer with superparamagnetic iron oxide nanoparticles are among the recent advances in nano-based drug delivery.

Outsourcing
Offshoring Biomanufacturing
Eric Langer, president of BioPlan Associates
Will international biomanufacturing outsourcing become mainstream in this decade?

Pharma Industry's Global Health and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.


Pharma Companies Increase R&D for Neglected Tropical Disease
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Pharma companies intensify R&D efforts to address treatments for neglected tropical diseases in the developing world.